Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?

To: Bill Rood who wrote (76710)	5/25/1999 11:42:00 AM
From: Trade4$	Read Replies (2) \| Respond to of 119973

Still $5.00 and under but not for long: When you think about what a name change did for XTON when it became ELOT, and what new Internet territory did for FLBK, it is not hard to imagine what DWNS could do. Combine that with near future announcements of new contracts and I believe that DWNS will not only shoot up, but that it will stay up and continue growing. The following announcement was published this morning: Downstream Announces the Acquisition of Q-Seven Systems, Inc. PR Newswire, Tuesday, May 25, 1999 at 08:49 SALT LAKE CITY, May 25 /PRNewswire/ -- Downstream Incorporated (BB: DWNS) is pleased to announce the acquisition of Q-Seven Systems, Inc. The acquisition makes Downstream, via its wholly owned subsidiary, Q-Seven Systems, Inc., the exclusive sales and licensing agent for the Q-Seven User Management System. In the coming weeks, Downstream plans to change its name to Q-Seven Systems, Inc. and to apply for a new trading symbol. The Company anticipates its shares will be trading on the Frankfurt Exchange in Germany in the coming months, as well as the OTC Bulletin Board in the US. It also plans to commence an extensive international public relations campaign. The management of Q-Seven believes its new User Management Software is one of the best software systems available for online gambling, adult entertainment, other forms of e-commerce and secure online billing. Management further believes its state of the art software will attract many new licensees in the coming year, and that it will be able to announce several new licensees in the near future. According to Datamonitor (London) online gambling revenues will reach a staggering $10 billion by the year 2002. Revenues for the average online casino are currently $4-5 million annually. Online gambling profits dwarf those of all other online services. Q-Seven faces competition in the online gaming market from companies such as Anchor Gaming Inc.; Trans World Gaming Group; Argosy Gaming Co.; International Game Technology Inc.; Starnet Communications; Cybergames Inc.; Global Games Corp.; Cryptologic Inc.; GLC Limited; and Playboy Enterprises in the adult market. The management of Downstream cautions readers not to place undue reliance on "forward-looking statements," such as "plans to," "is expected to," etc. which speak only as of the date made, when used in this press release, in filings with the SEC, in other public or stockholder communications, or in oral statements made with the approval of an authorized executive officer of the Company. Such statements are based on certain assumptions and expectations which may or may not actually occur and which involve various risks and uncertainties. SOURCE Downstream Incorporated · 0- 05/25/99 /CONTACT: Philipp Kriependorf of Q-Seven Systems, Inc., 011-49-2173-330-3630/ Companies or Securities discussed in this article: Symbol Name BB:DWNS Downstream Inc

To: Bill Rood who wrote (76710)	5/25/1999 2:57:00 PM
From: VeloSpeed	Read Replies (2) \| Respond to of 119973

CMPD news looks great! CompuMed Receives FDA Marketing Clearance for Automated OsteoGram(R) 2000 PR Newswire - May 25, 1999 10:19 Breakthrough Technology Will Enable Physicians Worldwide to Perform Simple and Highly Accurate Osteoporosis Tests in Their Own Offices MANHATTAN BEACH, Calif., May 25 /PRNewswire/ -- CompuMed, Inc. (Nasdaq: CMPD) announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) to begin marketing its Automated OsteoGram(R) 2000, the world's first device that enables physicians to perform convenient and accurate bone density tests in their own offices utilizing their existing standard x-ray equipment. Over 100,000 facilities in the U.S. and over 1 million facilities worldwide already have the standard x-ray equipment required to perform the procedure. The potential worldwide market for devices such as the Automated OsteoGram 2000 system is estimated to exceed $2 billion. "This is a breakthrough product with significant implications for patients and physicians everywhere," said Michael A. Davis, M.D., D.Sc., Professor of Radiology and Director of Radiologic Research at the University of Massachusetts Medical Center. "The market for a low-cost yet highly accurate bone densitometry test in physicians' offices is enormous. Currently, only a few thousand bone densitometers are scattered throughout the U.S. and the rest of the world, mainly in specialized osteoporosis centers. Now, physicians everywhere will have access to a practical and reliable way of evaluating and treating the millions of patients at risk for osteoporosis," added Dr. Davis. The Automated OsteoGram 2000 system consists of a desktop scanner, standard PC and OsteoGram bone density analysis software. A simple hand x-ray is taken, then scanned into the computer for automated analysis. The procedure takes less than one minute to perform, and is approved for reimbursement by Medicare and the vast majority of third-party payors in the U.S. The list price for the entire system will be substantially lower than the cost of bone densitometers on the market today, while offering unsurpassed clinical performance. In a landmark 3-year study sponsored by Merck & Co., Inc.(NYSE: MRK), the U.S. Public Health Service and the Hawaii Osteoporosis Foundation, published in November, 1998, the OsteoGram achieved the highest osteoporosis prediction score of any bone density test ever. The Automated OsteoGram 2000 can also precisely monitor changes in bone mass over time. "Since one in two women and one in five men alive in the U.S. today are likely to suffer hip, spine or wrist fractures caused by osteoporosis, and effective therapies exist that can dramatically reduce that risk, it is necessary for doctors to have the tools to manage osteoporosis in their own offices," stated James Linesch, President of CompuMed. "We are very proud to have created the diagnostic technology that will finally make that possible." CompuMed, based in Manhattan Beach, California, develops solutions to important medical problems through the use of computer technology. In addition to the Automated OsteoGram 2000, CompuMed is developing the Digital OsteoView(R) 2000, which will combine the Automated OsteoGram software with the world's first automated test for arthritis. The developmental OsteoView technology utilizes a filmless digital x-ray detector developed by Varian Medical Systems (NYSE: VAR) and Xerox Corporation (NYSE: XRX), under a grant from the U.S. Defense Advanced Research Projects Agency (DARPA). CompuMed is also working with The Johns Hopkins University Medical School and Applied Physics Laboratory to create the first device that can measure bone structure in three dimensions (3-D), to even more accurately assess the risk of future fractures and monitor bone changes over time. CompuMed has also developed computer-aided diagnostic telemedicine services for cardiology and currently provides on-line computer interpretation of electrocardiograms (EKGs) to physicians, government and corporate healthcare providers.